MFS
IRWD icon

Mirabella Financial Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mirabella Financial Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,101
Closed -$65.9K – 316
2024
Q2 		$65.9K Buy
+10,101
New +$71.4K ﹤0.01% 412
2022
Q3 		– Sell
-21,580
Closed -$249K – 452
2022
Q2 		$249K Buy
+21,580
New +$254K 0.02% 374

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirabella Financial Services's IRWD Position: Q3 2024 in Review

Mirabella Financial Services sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 10,101 shares — an estimated $65.9K sold.

Mirabella Financial Services first reported a position in IRWD in Q2 2022 and held it in 2 quarters. The position peaked at $249K in Q2 2022. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Mirabella Financial Services reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 10,101 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $65.9K.
  • Mirabella Financial Services first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 2 quarters.
  • Mirabella Financial Services's Ironwood Pharmaceuticals position peaked at $249K in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.